. 2020 Sep 20;116(2):234–238. doi: 10.1111/vox.13000

Table 2.

Alloantibodies encountered during the most recent 10 years (2008–2017) in patients at MMH and among blood donors at the Taiwan Blood Foundation

MMH [6] Total no. of patients: 38 537		Taiwan Blood Foundation [5] Total no. of blood donors: 3 510 131
Anti‐	No.	Anti‐	No.
‘Mi ^a ’	1002	‘Mi ^a ’	7015
E	906	P1	3159
c	367	Le ^a	2440
P1	257	E	2281
Le ^a	198	Le^b	1660
M	193	M	1537
C	73	c	283
Le^b	70	Wr ^a	165
Di ^a	60	D	146
e	58	S	138
Jk ^a	58	e	116
Jk^b	42	Di ^a	97
Wr ^a	40	C	94
D	22	Fy^b	43
Fy^b	19	N	40
S	18	G	13
Bg ^a	16	Jk ^a	8
N	13	Jk^b	4
Bg^b	7	Le^bh	4
Fy ^a	1	Jk3	3
Jk3	1	Ce, Cw, Di^b, M^g, Pr	2
i	1	V, PP1P^k, Vw, He, Kp ^a , Ku, Lan, Jr ^a , LW, Lw ^a	1
Total	3422 (8·9%) ^a	Total	19 266 (0·55%) ^a

Antibody screening and identification were performed by the manual Polybrene method at MMH and on an Olympus PK7300 analyser (0·3% bromelinized screening cells on a specially designed microplate) at Taiwan Blood Foundation. Anti‐I/HI and cold agglutinins were excluded.

^{^a}

Frequency (%) of alloantibodies encountered in patients and blood donors.